Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EDDA Technology is a global leader in advanced medical imaging and robotic surgery solutions, specializing in AI-powered precision treatment for oncology. The company's proprietary IQQA platform provides a comprehensive suite of tools for pre-operative planning, intra-operative guidance, and post-operative evaluation, particularly for complex abdominal and thoracic surgeries. Its flagship products, including IQQA-3D and IQQA-Guide, enable surgeons to perform minimally invasive and robotic-assisted procedures with enhanced accuracy and efficiency. Headquartered in Princeton, New Jersey, with major operations in China, EDDA Technology bridges the gap between diagnostic imaging and clinical intervention. The company's technology is utilized in hundreds of hospitals worldwide to support the treatment of liver, lung, and kidney cancers. Through its integration of computer vision and surgical robotics, EDDA continues to advance the standard of care in precision surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EDDA Technology.